|
|
||||||||
Pulmonary and Critical Care Division, Long Island Jewish Medical Center, Long Island Campus for the Albert Einstein College of Medicine, New Hyde Park, New York 11042
Chen, Ling, and Steven M. Scharf. Comparative
hemodynamic effects of periodic obstructive and simulated central
apneas in sedated pigs. J. Appl.
Physiol. 83(2): 485-494, 1997.
It has been
speculated that because of increased left ventricular (LV) afterload,
decreased intrathoracic pressure (ITP) is responsible for decreased
cardiac output (CO) in obstructive sleep apnea. If this were true, then
obstructive apnea (OA) should have a greater effect on CO than would
central apnea (CA). To assess the importance of decreased
ITP during OA, we studied seven preinstrumented sedated pigs with OA
and simulated CA that were matched for blood gases and apnea
periodicities (with 15- or 30-s apnea duration). Compared with OA, CA
with 30-s apnea duration produced comparable decreases in heart rate
(from baseline to end apnea: OA, 106.6 ± 4.8 to 93.4 ± 4.4 beats/min, P < 0.01; and CA, 111.1 ± 6.2 to 94.0 ± 5.2 beats/min,
P < 0.01) and comparable increases
in LV end-diastolic pressure and LV end-diastolic myocardial segment
length but greater increases in mean arterial pressure (97.1 ± 3.7 to 107.7 ± 4.3 Torr, P < 0.05;
and 97.3 ± 4.8 to 119.3 ± 7.4 Torr,
P < 0.01) and systemic vascular
resistance (2,577 ± 224 to 3,346 ± 400 dyn · s · cm
5,
P < 0.01; and 2,738 ± 294 to
5,111 ± 1,181 dyn · s · cm
5,
P < 0.01) and greater decreases in
CO (3.18 ± 0.31 to 2.74 ± 0.26 l/min,
P < 0.05; and 3.07 ± 0.38 to
2.30 ± 0.36 l/min, P < 0.01) and
stroke volume (32.2 ± 2.9 to 25.9 ± 2.4 ml,
P < 0.05; and 31.5 ± 1.9 to 19.8 ± 3.1 ml, P < 0.01). Only CA increased LV end-systolic myocardial
segment length. Similar findings were observed with 15-s apnea
duration. We conclude that CA produced greater depression of CO and
greater changes of afterload-related LV dysfunction than did OA.
Therefore, decreased ITP was not the dominant factor determining LV
function with apneas.
sleep apnea; left ventricular function; hypoxia
SLEEP APNEA, which has high prevalence and wide-ranging
sequelae, is increasingly being recognized as a public health problem (14). Numerous investigations have explored various
aspects of acute cardiovascular changes induced by sleep apnea. For
example, the oscillation of heart rate (HR) and systemic arterial
pressure during apneas has been well documented (2). However, the
effects on left ventricular (LV) function are not well understood.
The interactions of several factors, including intrathoracic pressure
(ITP), systemic hypoxemia, and disruption of sleep architecture, have
been reported to be responsible for acute cardiovascular effects of
obstructive sleep apnea (2). However, the relative importance of each
factor remains unclear. Inspiratory ITP may decrease considerably
during obstructive apneas (OAs) (10). This leads to increased right
ventricular preload (venous return) and can produce substantial
inspiratory increases in right ventricular end-diastolic pressure and
stroke volume (SV) (17). In addition, it has been suggested that the
large inspiratory swings in ITP that occur with OA lead to increased LV
afterload and may contribute to decreased cardiac output (CO) during
apneas (5, 25). While sustained decreases in ITP (Mueller maneuver) are
associated with increased LV afterload (16, 18), the effects of phasic
swings in ITP may be dominated by preload (27). Several recent reports suggest that mechanical factors play relatively minor roles in the
oscillation of mean arterial pressure (MAP) during the apnea and the
interapneic phase (12, 13, 27, 30). In this regard, apneas are
associated with changes in sympathoadrenal tone due to hypoxia and
arousal. It is possible that these reflex effects are more important
than are changes in LV function due to mechanical effects (decreased
ITP).
To evaluate the role of decreased ITP in influencing the cardiac
effects of apneas, we used previously instrumented sedated pigs and
studied the effects of two types of apneas matched for periodicity and
blood-gas changes: OA (with decreased ITP) and simulated central apneas
(CAs; without changes in ITP). We tested the hypothesis that because of
decreasing ITP, which would act additively with blood-gas changes, the
effects of OA on LV function would be more severe than those of CA.
The study was carried out in two phases: sterile instrumentation and
data collection. All methods, protocols, anesthesia, and sedation were
approved by the local Institutional Animal Care and Use Committee in
accordance with National Institutes of Health guidelines.
Instrumentation Phase
Data-Collection Phase
Five days after the initial surgery, the animals were anesthetized with an intramuscular injection of ketamine (2 mg/kg). This induced 30-40 min of surgical anesthesia. Animals were intubated and breathed through an endotracheal tube for the duration of the studies. A large-bore catheter was placed in the femoral vein for administration of fluids and medications. The cutdown was closed, and the animal was placed on its right side. A continuous intravenous drip with a mixture of 0.9% alphaxalone and 0.3% alphadolone acetate (Saffan, Pittman-Moore, Uxbridge, Middlesex, UK), at a dose of 3 mg · kg
1 · h
1
of total steroid, was instituted. This produced a state of
moderate sedation in which animals appeared comfortable and corneal
reflexes were preserved. Responses to superficial pain were not seen,
but the animals did respond to severely painful stimuli. Under local anesthesia with 2% lidocaine, a 7-F thermistor-tipped catheter was
inserted into the femoral artery via cutdown and advanced into the
ascending aorta for measurement of blood pressure, measurement of CO by
thermodilution, and blood-gas sampling. The subcutaneous pocket was
opened under local anesthesia, and the ends of the left atrial catheter
and the wires of the aortic flow (
ao) probe and LV
crystals were exposed. The plastic plug was removed from the left
atrial catheter, and a plastic head with a one-way valve and sidearm
was placed to serve for insertion of a 5-F micrometer-tipped catheter
(Millar Instrument, Houston, TX) into the LV for high-fidelity recording of LV pressure. The sidearm of the left atrial catheter served for injection of iced saline into the left atrium for
measurements of CO. Sonomicrometer crystal leads,
ao probe, and pulse oximeter were connected to the
recording devices. The signals from the
ao probe
were recorded via a direct-current amplifier and were electronically
integrated for beat-by-beat measurement of LV SV. Airway pressure was
measured via a lateral tap placed between the pneumotachograph and the
endotracheal tube and connected to a differential transducer (Validyne,
Northridge, CA).
Experimental Protocols
OA was caused by occlusion of the endotracheal tube, alternating with spontaneous ventilation during the interapneic interval. CA was simulated by paralyzing the animals with succinylcholine (first dose 2 mg/kg by iv injection and then 12 mg · kg
1 · h
1
by continuous iv infusion) and maintaining the animals under mechanical
ventilation. The ventilator was turned on and off at periodicities set
to match those of OA. Tidal volume was set at 12 ml/kg. Ventilatory
rate during mechanical ventilation was adjusted at baseline to match
arterial PCO2 seen with OA baseline. Occlusion (with OA) or turning the ventilator off (with CA) was done at
end expiration. Apnea periodicities are expressed as two numbers:
a/b, where
a refers to the length of time that
the animal was apneic and b refers to
the interapneic interval. We tested the effects of two periodicities:
15/45 (15-s apnea and 45-s interapneic interval) and 30/30 (30-s apnea
and 30-s interapneic interval). Thus, with both periodicities, an
apnea-interapnea cycle was defined as 1 min.
Data Acquisition and Calculations
Measurements were done at baseline, during the fifth apnea-interapnea cycle, and at recovery. The word baseline indicates the period of ventilation after a 20-min stabilization under experimental conditions but before any apneic intervention. Recovery means the state after a 20-min stabilization under baseline conditions after the apneic intervention. During the fifth apnea-interapnea cycle, hemodynamics and airway pressure were recorded over the entire cycle, and blood samples for arterial blood gases were taken during a period of 10 s, from 5 s before the apnea termination to 5 s into the interapneic interval. Data were digitized at a frequency of 128 Hz in 60-s epochs and streamed through to a hard disk of a microcomputer by using commercially available software (ACQ4600, Gould, Cleveland, OH). The following data were recorded: blood pressure, LV pressure, instantaneous
ao, SV, LV myocardial segment length, and airway pressure.
Data were analyzed off-line by using commercially available software
(View II, Gould). Data during the fifth apnea-interapnea cycle were
taken at specified times (Fig. 1) as
follows: early apnea, late apnea, early interapnea, late interapnea,
midapnea (for 30/30), and end interapnea (for 15/45). Each data point
represented a 5-s period. HR and MAP were measured as mean values from
blood pressure tracing, and CO was measured from
ao. The flow probe signals were calibrated at each
baseline by using the thermodilution technique. SV, LV pressure, and
myocardial segment length were measured in duplicate or triplicate on a
beat-to-beat basis and at end expiration as seen on the airway pressure
tracing. Both LV pressure and myocardial segment lengths were measured
at end diastole (LVEDL) and end systole (LVESL). End diastole was
defined as the point of rapid upstroke of the LV tracing. End systole was defined as the zero crossing of the
ao after
ejection. Systemic vascular resistance (SVR) was calculated as
(MAP/CO) · 79.9 (dyn · s · cm
5).
For OA, we measured the largest difference between inspiratory and
expiratory airway pressures during apnea. At constant lung volume, this
is assumed equal to the maximum swing in ITP.
Statistical Analysis
Data were compiled and expressed as means ± SE. Differences between baseline and recovery, as well as between OA and CA at baseline and recovery, were assessed by using Student's t-test for paired variates. One-way analysis of variance for repeated measures was used to test for significant differences between baseline and all points during the apnea-interapnea cycle, as well as to test changes within the apnea-interapnea cycle for each condition. Separate analyses were used to compare baseline with the apnea-interapnea and for comparisons of values within the apnea-interapnea cycle. If significance was found, a Newman-Keuls procedure was used to analyze the difference between each pair of values. Two-way analysis of variance was used for testing the differences between OA and CA from baseline to the apnea-interapnea cycle. The null hypothesis was rejected at the 5% level.Blood Gases, Airway Pressure, and Preparation Stability
Table 1 demonstrates the changes in blood gases and airway pressure. OA induced exaggerated inspiratory swings in airway pressure during apneas. There were no significant differences in blood-gas values between recovery and baseline, or between OA and CA, for either periodicity. As expected, the longer the apnea duration the greater the change in blood-gas values and swings in airway pressure (for OA). In addition, there were no significant differences between baseline and recovery under any conditions for MAP, CO, HR, SV, LVEDP, LVEDL, LVESL, or SVR. Thus this preparation demonstrated no time-related deterioration.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hemodynamic Effects
Figures 2 and 3 demonstrate examples of airway pressure and hemodynamics at baseline and over the fifth apnea-interapnea cycle in a representative pig with OA (Fig. 2) and CA 30/30 (Fig. 3). With OA, there were fluctuations of airway pressure during the apneic phase. Both apnea types were associated with increases in MAP and LV pressure and lengths as well as decreases in HR,
ao, and SV. CA (Fig. 3) caused
greater changes in MAP,
ao, and LV pressure and
lengths compared with OA (Fig. 2), although blood gases at end apnea
and apnea periodicity were the same.
ao), left ventricular pressure (LVP), stroke volume (SV), and left ventricular myocardial segment length (LVL); baseline, measurement before any apnea manipulation. Note that obstructive apneas caused large swings in Paw. Moreover, compared with
baseline, there were higher systolic and diastolic BPs, LVP, and LVL
but lower
ao and SV during apnea-interapnea
cycle.
We present the comparision of the hemodynamic values as follows: 1) changes relative to baseline, 2) changes within the apnea-interapnea cycle, 3) differences between OA and CA, and 4) differences between short- and long-duration apneas.
Changes during the cycle vs. baseline. Relative to baseline, MAP (Fig. 4) increased significantly except at end interapnea for periodicity 15/45 OA. CO (Fig. 5) was significantly lower than baseline only at late apnea and early interapnea for periodicity 15/45 for both OA and CA. However, for periodicity 30/30, CO was decreased significantly at almost all points in the apnea-interapnea cycle for both OA and CA. With OA, for both periodicities, HR (Fig. 6) was significantly less than baseline at all points except at late interapnea with 30/30 and at end interapnea with 15/45. However, with CA, HR decreased only at midapnea for 30/30 and late apnea for both periodicities. With CA, SV (Fig. 7) was significantly lower than baseline at every point during the cycle except at end interapnea with 15/45. For OA, SV was less than baseline only with 30/30 at late apnea and early interapnea. For both periodicities, LVEDP (Fig. 8) increased significantly at late apnea with OA and at every point for CA except at end interapnea with 15/45. With periodicity 30/30 for both OA and CA, LVEDL (Fig. 9) increased significantly at all points except at late interapnea for CA. With 15/45, LVEDL increased at late apnea and early interapnea for both apnea types and at early apnea with OA. LVESL (Fig. 10) increased significantly only at late apnea and early interapnea with CA of both periodicities but did not increase at all with OA. SVR (Fig. 11) increased significantly under all conditions and at all points except for late and end interapnea of OA 15/45.
Changes within the apnea-interapnea cycle. MAP (Fig. 4) did not change during the apnea-interapnea cycle compared with early apnea. CO (Fig. 5) decreased significantly relative to early apnea only with periodicity 30/30 for CA and only at early interapnea. HR (Fig. 6) decreased significantly relative to early apnea only at late apnea and with periodicity 30/30 for CA. SV (Fig. 7) decreased significantly relative early apnea only at early interapnea with CA for both periodicities. LVEDP (Fig. 8) increased relative to early apnea with CA 15/45 and relative to late apnea with CA and OA 30/30. LVEDL (Fig. 9) increased relative to early apnea with CA for both periodicities at late apnea and with CA 15/45 at early interapnea. There were no significant changes in LVESL (Fig. 10) compared with early apnea. SVR (Fig. 11) increased relative to early apnea with CA for both periodicities at early interapnea. When changes from late apnea to early interapnea were compared with CA 30/30, there were significant increases in HR (P < 0.01) and SVR (P < 0.01) and decreases in LVEDL (P < 0.01). For OA, only LVEDP decreased from late apnea to early interapnea (P < 0.01). OA vs. CA. With both periodicities, CA was associated with a significantly higher MAP (Fig. 4) and SVR (Fig. 11) than was OA. In addition, CA 30/30 caused greater decreases in CO (Fig. 5) and SV (Fig. 7) than did OA 30/30. For both periodicities of OA, there were significantly greater decreases in HR (Fig. 6) than for those of CA, but the minimum HR (at late apnea) was the same for both apnea types. Effects of apnea periodicities. Compared with CA 15/45, CA 30/30 was associated with greater decreases in CO (late apnea, P < 0.05) and in SV (late apnea and early interapnea, both P < 0.05) and greater increases in SVR (late apnea, P < 0.05) and in LVEDP (early interapnea, P < 0.05). With OA, there were no significant differences in hemodynamics between the two periodicities.
In this study, we compared the hemodynamic responses to OA and CA when matched for apnea periodicities and blood-gas changes. There were three principal findings. 1) Both OA and CA were associated with decreased HR and CO and increased MAP compared with baseline. However, changes were more exaggerated with CA. 2) Although changes in preload were comparable under both conditions, changes in afterload were greater with CA. 3) Although increased apnea duration was associated with more severe alteration in blood gases, and, for OA, with greater swings in airway pressure, changes in MAP and HR were comparable to those of short-duration apneas. However, for CA, CO and SV decreased more, and LVEDP and SVR increased more, with long compared with short apnea duration.
Experimental Preparation
In the present study, we modified a previously described anesthetized dog model of OA and CA (19, 26-28). Because the preparation utilized preinstrumented sedated pigs, cardiorespiratory depression caused by anesthesia and acute major surgery were minimized. Thus swings in ITP with OA were greater than those seen in the anesthetized dog model (Table 1; Refs. 19, 26, 28). Sleep apnea patients, as well as severe snorers, may generate changes in esophageal pressure of
37 to
60 Torr during the apneas (10). A number of authors
have demonstrated significant changes in LV hemodynamics with sustained
decreases in ITP of 20-40 Torr (11). In present study, with OA, changes in ITP as judged by the difference between inspiratory and expiratory airway pressures at iso-lung volume were
comparable to these values.
Alphaxalone and alphadolone acetate (Saffan) is known to preserve
autonomic components of the alerting reaction associated with
chemoreceptor stimulation (8) and to produce minimal suppression of
vagal and sympathetic activities associated with baroreceptor and
chemoreceptor function (1). We observed that, with a
continuous intravenous drip at 3 mg · kg
1 · h
1,
there was moderate sedation, but the animals preserved corneal reflexes, spontaneous ventilation, and responses to very loud noises
and severely painful stimuli. We observed no signs of distress such as
tachycardia during the paralysis phase, and we were careful to maintain
a continuous drip. In several animals, we doubled the dose of sedative
and observed the same response in blood pressure and HR reported here,
suggesting that the observed changes were not due to a nonspecific
response to pain or discomfort or inadequate sedation.
It would have been ideal to randomize the order in which animals received OA and CA. However, the wait for full recovery from paralysis prolonged the experiment considerably. We did reverse the order of applying CA and OA in two animals, and the results were not different from those of the other five.
There are several differences between clinical sleep apnea and our model. First, sedation is not equivalent to sleep. A previous study found spontaneous changes in cortical arousal during sedation with Saffan (21), such as spontaneous switch from predominantly delta to predominantly beta and theta waves. However, changes in the electroencephalogram state over the apnea-interapnea cycles suggestive of arousal reaction are not seen in this model (unpublished data). Second, our CA model differs from patients with CA during sleep. In patients, there is suppression of both afferent input from respiratory and chest wall mechanoreceptors as well as efferent output from respiratory centers. However, with paralysis-induced CA, afferent input from mechanoreceptors is eliminated, but efferent central output continues (20) and even increases progressively during apnea. Thus CA-mediated cardiorespiratory coupling continues. Although in anesthetized animals this leads to swings in MAP (27, 28) during the apnea, these swings were not observed in our sedated animals. Finally, patients with sleep apnea usually take several large tidal volume breaths immediately after apnea termination. In contrast, our CA model was terminated by resumption of tidal volumes from the ventilator, which were unchanged from baseline. It is possible that differences in postapneic breathing pattern influenced the difference between OA and CA immediate after apnea termination, even though blood-gas values were identical at end apnea with OA and CA.
Hemodynamic Effects: Apnea Type
Although numerous investigations have explored the blood pressure and HR response to OA, because of the difficulties in measuring CO and LV dimensions on a beat-by-beat basis during the respiratory cycle in patients with sleep apnea, there have been few studies that have examined beat-by-beat changes in cardiac function. Thermodilution methods only provide CO data averaged over several cardiac cycles. Thus it is not surprising that earlier studies (7, 15) reported variable trends in CO. There are several recent clinical studies that used noninvasive beat-by-beat techniques, including thoracic electrical impedance (25, 31) or nuclear cardiographic devices (5, 6). Tolle et al. (29) reported that both LV SV and HR decreased during the apnea compared with values when the patients were awake, leading to a substantial (27%) reduction in CO. They speculated that decreased SV was attributable to a reduction in preload. Stoohs and Guilleminault (25) reported a decrease in SV during obstructive apneas but no further change in SV during the interapnea interval. Using a nuclear cardiographic technique to monitor LV volume, Garpestad et al. (5, 6) reported a significant decrease in SV from early apnea to late apnea and a further decrease immediately after apnea termination (early interapnea). Because of the inverse relationship between afterload (MAP) and SV, Garpestad et al. suggested that increased afterload was responsible for decreased SV. However, artifacts caused by lung inflation and body movements, as well as difficulties in calibration, limit collection of data and interpretation of these results.In present study, both OA and CA were associated with increased LV afterload as measured by MAP and with decreased CO during apnea. Increased MAP was likely related to arterial constriction, as reflected by the increase in SVR. With OA, changes in CO reflected primarily changes in HR, although with OA 30/30 decreased SV at late apnea and early interapnea also contributed to changes in CO. However, with CA, decreased CO reflected decreases in both SV and HR. It is likely that the decrease in SV with CA was due to the greater increase in LV afterload with this type of apnea. This is shown by the fact that although changes in preload as measured by LVEDL and LVEDP were the same for CA as for OA, indexes of afterload such as LVESL and MAP increased more with CA. We cannot rule out changes in cardiac contractility with CA, which could contribute to these effects; however, we think this possibility is unlikely.
In this study, the maximum decrease in HR (at late apnea) during apneas compared with baseline was approximately the same for OA and CA (12-16% from baseline). In previous studies from this laboratory in which anesthetized dogs were used, HR decreased 24-27% with OA (19, 26, 27) and 44-47% with CA (27, 28). It has been postulated that reflex autonomic activation is involved in cardiovascular responses to the apneas. Therefore, the differences in HR between the present study and the previous studies may reflect less depression of sympathoadrenal tone in sedated vs. anesthetized animals. Differences in responses could also reflect species differences.
We did not record inspiratory-expiratory differences in LV function. During loaded inspiration, LV afterload may increase and preload may decrease (16, 19). It could be argued that by recording only at end expiration these effects were missed. However, trends in CO measured over several cardiac cycles, and at least one respiratory cycle, agreed with those recorded directly from the flow probe at end expiration. Thus any effects attributable to changes in loading conditions during inspiration were likely to be small. The cardinal point here is that although there may be some changes during inspiration associated with ITP, these were clearly dominated by changes in MAP and SVR, which were greater when ITP did not change (CA).
There are several reasons that may explain the differences in hemodynamic responses to apneas between OA and CA. We originally postulated that LV afterload effects of decreasing ITP would render OA a more severe depressant of CO. However, the present study showed that CA elicited more profound changes in MAP and LV function than did OA. One possible reason is that CA elicits a greater sympathetic neural response than does OA. Thus these findings suggest that changes in afterload due to neural reflex mechanisms, not to decreased ITP, are the dominant factor controlling CO. These conclusions are consistent with previous work. In conscious humans, development of a large negative ITP during a 20-s Mueller maneuver augmented MAP and postganglionic muscular sympathetic nerve activity less than did a simple breath hold of comparable duration made at end expiration (12). In the autonomically blocked dog, there was no increase in MAP either during or after a period of airway obstruction in non-rapid-eye-movement sleep, and, in fact, MAP fell in the postobstructive period whether or not arousal occurred (13). In anesthetized baboons with OA and paralysis-induced CA, MAP elevation in OA and CA did not differ for any duration apnea, and HR remained the same with both apnea types (30). In that study, White et al. (30) measured CO by thermodilution and reported no difference in CO between OA and CA. In anesthetized dogs, Tarasiuk and Scharf (27) found HR and CO decreased more with CA compared with OA when matched for blood gases and apnea periodicity, although neither changed MAP. Unlike the present study, however, changes in CO were due to decreased HR because SV did not change. The present study thus extends the above observations and demonstrates that increases in MAP were more exaggerated and were associated with greater decrease in SV with CA than OA.
One possible explanation for the attenuated MAP and SVR response in OA compared with CA is that negative ITP suppressed the sympathetic response engendered by hypoxia. Somers et al. (23) demonstrated this in normal humans by comparing blood pressure and sympathetic responses to a Mueller maneuver maintained for 20 s to effects of an equal period of end-expiratory apnea. They suggested that dilation of the LV associated with the Mueller maneuver stimulated LV afferents, which decreased sympathetic activity. It is equally possible, however, that increased aortic baroreceptor transmural pressure during obstructed inspirations could have the same effect (3). Another possibility is that with OA hypoxic reflexes may be modified from right atrial distension or pulmonary congestion related to increased venous return during inspiration.
Blood pressure changes during and after apnea have been attributed to the interaction between the reflexes related to hypoxia and those of arousal (2). Because arousal during the apneas is not observed in the present model (unpublished data), changes in MAP are most likely due to the effects of hypoxemia and/or hypercapnia. However, they are modified by the apnea type. Early studies on steady-state hypoxia also reported that ventilatory pattern influences the cardiovascular response (9). The afferent reflexes responsible for these differences are not known. One possibility is that the differences between OA and CA are due to afferent inputs from respiratory and other skeletal muscles with OA. For example, the increases in muscle sympathetic nerve activity from the stimulation of chemoreceptors in awake humans can be augmented by voluntary apneas (23, 24). These results suggest that the loss of inputs from lung or chest wall afferents or intrathoracic receptors may modify chemoreceptor activation of the autonomic nervous system. With CA and OA, HR increased considerably during early interapnea (with resumption of breathing) compared with late apnea, although only increases with CA showed statistical significance (Fig. 6). This rapid rise in HR, within one to two breaths, was also noted in previous studies in anesthetized dogs (27, 28). It is unlikely that changes in HR of this rapidity can be explained by changes in blood gases. It is more likely that they are due to pulmonary stretch receptor stimulation associated with lung inflation (9, 27). Thus the interaction of blood-gas changes, pulmonary parenchymal, intrathoracic vascular, and possibly chest wall mechanoreceptors determines the overall response. Finally, increased MAP would also be expected to invoke baroreceptor responses. However, unmodified baroreceptor responses are not likely to be responsible for changes in HR. This is because with CA, MAP at early apnea was greater than with OA. Yet initial HR was greater with CA. During the apnea phase, MAP did not increase significantly (compared with early apnea), yet with CA, HR fell during the apnea phase. Thus, although baroreceptor reflexes may contribute to changes in HR, it would appear that there must be a modification of the set point and/or sensitivity.
Hemodynamic Effects: Apnea Duration
Increasing apnea duration and decreasing interapnea time caused more severe hypoxia and hypercapnia. However, there are surprisingly few hemodynamic differences between the apnea durations for OA. With CA 30/30, CO, SV, and SVR at late apnea, and LVEDL at early interapnea, were more affected than with CA 15/45. Other variables changed similarly between the two apnea durations. One reason that long apnea duration might not result in more severe cardiovascular responses with OA is that hypoxia induces coactivation of two antagonistic mechanisms, i.e., sympathetic and parasympathetic responses (4). Furthermore, the local vascular effects of hypoxia are inhibitory and tend to reduce blood pressure by vasodilation. The interplay of these antagonistic mechanisms may prevent consistent changes in blood pressure despite greater blood-gas changes. Second, the confounding effects of chest wall and lung mechanoreceptors and/or intrathoracic vascular receptors may dampen the effects of worsening hypoxemia with OA.These studies may have clinical relevance, especially in patients with compromised LV function. Many of these patents exhibit Cheyne-Stokes breathing at night. If the CA phase of Cheyne-Stokes breathing results in elevated MAP and SVR, as does the simulated CA in our studies, this could, by increasing LV afterload, further compromise LV function and adversely affect clinical outcome.
In summary, when matched for periodicity and blood-gas changes, CA produced greater depression of CO and was associated with greater changes of afterload-related LV dysfunction compared with OA. This was likely related to a greater increase in MAP and LV afterload with CA. Therefore, decreased ITP plays only a small role in determining LV function with OA. The reason for the greater effects of CA are unknown, but loss of mechanoreceptor or pulmonary vascular receptor afferent input may be responsible.
The authors gratefully acknowledge Michael DiBlasi and Lisa S. DePrisco for expert technical assistance.
Address for reprint requests: S. M. Scharf, Long Island Jewish Medical Center, Pulmonary and Critical Care Div., New Hyde Park, NY 11042.
Received 13 January 1997; accepted in final form 4 April 1997.
| 1. | Blake, D. W., and P. I. Korner. Effects of ketamine and althesin anesthesia on baroreceptor-heart rate reflex and hemodynamics of intact and pontine rabbits. J. Auton. Nerv. Syst. 5: 291-301, 1982[Medline]. |
| 2. | Bonsignore, M. R., O. Marrone, G. Insalaco, and G. Bonsignore. The cardiovascular effects of obstructive sleep apnoeas: analysis of pathogenic mechanisms. Eur. Respir. J. 7: 786-805, 1994[Abstract]. |
| 3. | Fitzgerald, R. S., J. L. Robotham, and A. Anand. Baroreceptor output during normal and obstructed breathing and Mueller maneuvers. Am. J. Physiol. 240 (Heart Circ. Physiol. 9): H721-H729. |
| 4. | Fukuda, Y., A. Sato, A. Suzuki, and A. Trzebski. Autonomic nerve and cardiovascular responses to changing blood oxygen and CO2 levels in the rat. J. Auton. Nerv. Syst. 28: 61-74, 1989[Medline]. |
| 5. |
Garpestad, E.,
H. Katayama,
J. A. Parker,
J. Ringer,
J. Lilly,
T. Yasuda,
R. H. Moore,
H. W. Strauss,
and
J. W. Weiss.
Stroke volume and cardiac output decrease at termination of obstructive apnea.
J. Appl. Physiol.
73:
1743-1748,
1992 |
| 6. |
Garpestad, E.,
J. A. Parker,
H. Katayama,
J. Lilly,
T. Yasuda,
J. Ringer,
H. W. Strauss,
and
J. W. Weiss.
Decrease in ventricular stroke volume at apnea termination is independent of oxygen desaturation.
J. Appl. Physiol.
77:
1602-1608,
1994 |
| 7. |
Guilleminault, C.,
J. Motta,
F. Mihm,
and
K. Melvin.
Obstructive sleep apnea and cardiac index.
Chest
89:
331-334,
1986 |
| 8. |
Hilton, S. M.,
and
J. M. Marshall.
The pattern of cardiovascular response to carotid chemoreceptor stimulation in the cat.
J. Physiol. (Lond.)
326:
495-513,
1982 |
| 9. | Levinson, P. D., and B. R. Millman. Causes and consequences of blood pressure alterations in obstructive sleep apnea. Arch. Intern. Med. 151: 455-462, 1991[Abstract]. |
| 10. | Lugaresi, E., F. Cirignotta, G. Coccagna, and P. Montagna. Clinical significance of snoring. In: Sleep and Breathing, edited by C. E. Sullivan, and N. A. Saunders. New York: Dekker, 1984, vol. 21, p. 283-298. (Lung Biol. Health Dis. Ser.) |
| 11. | McIntyre, K., and S. M. Scharf. The use of Valsalva's and Mueller's maneuvers as diagnostic tests for coronary artery disease. In: Heart-Lung Interactions in Health and Disease, edited by S. M. Scharf, and S. S. Cassidy. New York: Dekker, 1989, vol. 42, p. 1021-1046. (Lung Biol. Health Dis. Ser.) |
| 12. |
Morgan, B. J.,
T. Denahan,
and
T. J. Ebert.
Neurocirculatory consequences of negative intrathoracic pressure vs. asphyxia during voluntary apnea.
J. Appl. Physiol.
74:
2969-2975,
1993 |
| 13. |
O'Donnell, C. P.,
T. Ayuse,
E. D. King,
A. R. Schwartz,
P. L. Smith,
and
J. L. Robotham.
Airway obstruction during sleep increases blood pressure without arousal.
J. Appl. Physiol.
80:
773-781,
1996 |
| 14. |
Phillipson, E. A.
Sleep apnea a major public health problem.
N. Engl. J. Med.
328:
1271-1273,
1993 |
| 15. | Podszus, T., J. Mayer, T. Penzel, J. Peter, and P. von Wichert. Nocturnal hemodynamics in patients with sleep apnea. Eur. J. Respir. Dis. 69: 435-442, 1986. |
| 16. | Scharf, S. M. Influence of sleep state and breathing on cardiovascular function. In: Sleep and Breathing, edited by C. E. Sullivan, and N. A. Saunders. New York: Dekker, 1984, vol. 21, p. 221-240. (Lung Biol. Health Dis. Ser.) |
| 17. | Scharf, S. M. The effect of decreased intrathoracic pressure on ventricular function. J. Sleep Res. 4, Suppl. 1: 53-58, 1995. |
| 18. |
Scharf, S. M.,
R. Brown,
D. E. Tow,
and
A. F. Parisi.
Cardiac effects of increased lung volume and decreased pleural pressure in man.
J. Appl. Physiol.
47:
257-262,
1979 |
| 19. | Scharf, S. M., L. M. Graver, and K. Balaban. Cardiovascular effects of periodic occlusions of the upper airways in dogs. Am. Rev. Respir. Dis. 146: 321-329, 1992[Medline]. |
| 20. | Shykoff, B. E., S. S. J. Naqvi, and A. S. Menon. Respiratory sinus arrhythmia in dogs: effects of phasic afferents and chemostimulation. J. Clin. Invest. 87: 1621-1627, 1991. |
| 21. | Sica, A. L., A. M. Steele, M. R. Gandhi, and N. Prasad. Factors affecting central inspiratory modulation of hypoglossal motoneuron activity in newborn pigs. J. Dev. Physiol. (Eynsham) 10: 285-295, 1988[Medline]. |
| 22. | Somers, V. K., M. E. Dyken, and J. L. Skinner. Autonomic and hemodynamic responses and interactions during the Mueller maneuver in humans. J. Auton. Nerv. Syst. 44: 253-259, 1993[Medline]. |
| 23. |
Somers, V. K.,
A. L. Mark,
D. C. Zavala,
and
F. M. Abboud.
Influence of ventilation and hypocapnia on sympathetic nerve responses to hypoxia in normal humans.
J. Appl. Physiol.
67:
2095-2100,
1989 |
| 24. |
Somers, V. K.,
A. L. Mark,
D. C. Zavala,
and
F. M. Abboud.
Contrasting effects of hypoxia and hypercapnia on ventilation and sympathetic activity in humans.
J. Appl. Physiol.
67:
2101-2106,
1989 |
| 25. |
Stoohs, R.,
and
C. Guilleminault.
Cardiovascular changes associated with obstructive sleep apnea syndrome.
J. Appl. Physiol.
72:
583-589,
1992 |
| 26. | Tarasiuk, A., and S. M. Scharf. Effects of periodic obstructive apneas on venous return in closed-chest dogs. Am. Rev. Respir. Dis. 148: 323-329, 1993[Medline]. |
| 27. | Tarasiuk, A., and S. M. Scharf. Cardiovascular effects of periodic obstructive and central apnoeas in dogs. Am. J. Respir. Crit. Care Med. 150: 83-89, 1994[Abstract]. |
| 28. | Tarasiuk, A., and S. M. Scharf. Mechanisms of circulatory depression during simulating central apneas in the anesthetized dog. J. Basic Clin. Physiol. Pharmacol. 5: 253-268, 1994[Medline]. |
| 29. |
Tolle, F.,
W. Judy,
P.-L. Yu,
and
O. Markand.
Reduced stroke volume related to pleural pressure in obstructive sleep apnea.
J. Appl. Physiol.
55:
1718-1724,
1983 |
| 30. |
White, S. G.,
E. C. Fletcher,
and
C. C. Moller III.
Acute systemic blood pressure elevation in obstructive and nonobstructive breath hold in primates.
J. Appl. Physiol.
79:
324-330,
1995 |
This article has been cited by other articles:
![]() |
J. Y. A. Foo, S. J. Wilson, A. P. Bradley, G. R. Williams, M.-A. Harris, and D. M. Cooper Use of Pulse Transit Time To Distinguish Respiratory Events From Tidal Breathing in Sleeping Children Chest, October 1, 2005; 128(4): 3013 - 3019. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. A. IMADOJEMU, K. GLEESON, K. S. GRAY, L. I. SINOWAY, and U. A. LEUENBERGER Obstructive Apnea during Sleep Is Associated with Peripheral Vasoconstriction Am. J. Respir. Crit. Care Med., January 1, 2002; 165(1): 61 - 66. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. T. LEUNG and T. DOUGLAS BRADLEY Sleep Apnea and Cardiovascular Disease Am. J. Respir. Crit. Care Med., December 15, 2001; 164(12): 2147 - 2165. [Full Text] [PDF] |
||||
![]() |
L. Chen and S. M. Scharf Effects of aortic nerve on hemodynamic response to obstructive apnea in sedated pigs J Appl Physiol, October 1, 2000; 89(4): 1455 - 1461. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Chen, Q. Shi, and S. M. Scharf Hemodynamic effects of periodic obstructive apneas in sedated pigs with congestive heart failure J Appl Physiol, March 1, 2000; 88(3): 1051 - 1060. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Schnader, M. N. Reddy, J. E. Heffner, and S. M. Scharf Clinical Conference On Management Dilemmas* : Obstructive Sleep Apnea And Respiratory Failure Chest, December 1, 1999; 116(6): 1786 - 1793. [Full Text] [PDF] |
||||
![]() |
J. D. PARKER, D. BROOKS, L. F. KOZAR, C. L. RENDER-TEIXEIRA, R. L. HORNER, T. DOUGLAS BRADLEY, and E. A. PHILLIPSON Acute and Chronic Effects of Airway Obstruction on Canine Left Ventricular Performance Am. J. Respir. Crit. Care Med., December 1, 1999; 160(6): 1888 - 1896. [Abstract] [Full Text] |
||||
![]() |
F. Tremel, J.-L. Pepin, D. Veale, B. Wuyam, J.-P. Siche, J.M. Mallion, and P. Levy High prevalence and persistence of sleep apnoea in patients referred for acute left ventricular failure and medically treated over 2 months Eur. Heart J., August 2, 1999; 20(16): 1201 - 1209. [Abstract] [PDF] |
||||
![]() |
D. Slamowitz, L. Chen, and S. M. Scharf Effects of vagotomy on cardiovascular response to periodic apneas in sedated pigs J Appl Physiol, June 1, 1999; 86(6): 1890 - 1896. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Chen, A. L. Sica, and S. M. Scharf Mechanisms of acute cardiovascular response to periodic apneas in sedated pigs J Appl Physiol, April 1, 1999; 86(4): 1236 - 1246. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Hall, S.-I. Ando, J. S. Floras, and T. D. Bradley Magnitude and time course of hemodynamic responses to Mueller maneuvers in patients with congestive heart failure J Appl Physiol, October 1, 1998; 85(4): 1476 - 1484. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Chen and S. M. Scharf Systemic and myocardial hemodynamics during periodic obstructive apneas in sedated pigs J Appl Physiol, April 1, 1998; 84(4): 1289 - 1298. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP |